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Coeliac disease (CD) is an autoimmune, gluten-related disorder occurring in genetically predisposed individuals. 
The keystone to CD management is a gluten-free diet (GFD). Recently, media have been promoting the application 
of a GFD, however, this is necessary only in gluten-related disorders. The aim of the present study was to evaluate 
the knowledge on CD among individuals, who conducted a self-administered coeliac disease test. Three hundred 
adult volunteers took part both in the anti-tissue transglutaminase screening and the survey concerning knowledge 
on CD. Five positive CD tests were obtained, representing 1.67% of the analysed population. In general, the 
questionnaire respondents were familiar with the issue of CD. The majority of them correctly defi ned CD as gluten 
intolerance, and realized that it may occur at any age. Gastrointestinal problems were easily associated with CD, 
however, extraintestinal symptoms were less frequently recognized as a manifestation of this disease. A GFD was 
properly identifi ed as a method of treating CD by 95% of the respondents. Self-administered, transglutaminase-
based screened persons presented a good level of knowledge on CD, regardless of their gender, place of residence, 
or education. However, dissemination of knowledge is needed, as CD is still an underestimated problem.
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Coeliac disease (CD) is an autoimmune disease occurring in genetically predisposed 
individuals. Genetic predisposition is associated with genes encoding the human leukocyte 
antigen (HLA), known as HLA-DQ2 and HLA-DQ8 (SAPONE et al., 2012). It is manifested 
by the chronic infl ammation of the small intestine, villous atrophy and hyperplastic lesions of 
the crypts in response to gluten ingestion. Classic, atypical and silent CD can be distinguished. 
In the classic example of CD, gastrointestinal symptoms, such as chronic diarrhoea, vomiting, 
and abdominal pain, are observed. Atypical CD, on the other hand, is characterized by minor 
and/or isolated symptoms (anaemia, osteoporosis, neurological disorders). In silent CD, 
patients report no symptoms, which contributes to problems with its correct diagnosis 
(SAPONE et al., 2012). Symptoms of CD may be age-dependent (ROMA et al., 2009), and 
extraintestinal symptoms occur more frequently in older children and adults (GUANDALINI & 
ASSIRI, 2014).
Until recently, the diagnosis of CD was based on the assessment of highly variable 
clinical status, assays of different specifi c antibodies, the histological evaluation of intestinal 
biopsies, and the response to a gluten-free diet (GFD) (GREEN & CELLIER, 2007). These days, 
most patients are diagnosed by endoscopy and biopsy following the positive results of 
serological tests (MOONEY et al., 2015). It is recommended to determine the level of anti-
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tissue transglutaminase (tTG) antibodies as the fi rst step of CD diagnosis. Other serological 
tests, such as anti-endomysial antibodies (EMA) and antibodies against deaminated gliadin 
peptides (DGP), may also be evaluated in certain cases. A positive result of the above-
mentioned serological tests allows one to suspect CD, however, for defi nite diagnosis, the 
confi rmation of a biopsy of the small intestine is needed.
It is estimated that approximately 1% of the general population suffers from CD (WEST 
et al., 2003), but a signifi cant percentage of the affected people go unrecognized or are 
diagnosed incorrectly (FASANO et al., 2003). Therefore, the serological population screening 
of groups at risk could be of value. Screening the population using conventional serological 
tests is expensive, diffi cult to organize, and requires qualifi ed staff and specialized equipment 
(KORPONAY-SZABÓ et al., 2007). Fortunately, faster methods of detecting antibodies have 
recently become available. They can be performed on a small blood sample from a fi nger and 
do not require the collection of venous blood samples.
Currently, CD has become a popular topic in the media. Information about the disease 
and portals and forums for patients as well as healthy people who want to learn more about 
the disease can be accessed easily. The media frenzy propagates a GFD, spreading knowledge 
concerning gluten and gluten-related disorders and expanding awareness on this subject. On 
the other hand, media promotes the application of a GFD without reasonable health 
rationalization. Therefore, it is important to take the available data in critically. The aim of 
the present study was to evaluate knowledge on CD among individuals who were interested 
in the topic for personal reasons (relatives of CD patients, individuals suffering from 
gastrointestinal problems, etc.) and conduct a self-administered transglutaminase-based test 
to determine how many people may actually be affected.
1. Materials and methods
An advertisement concerning CD testing was published in the local media. Individuals who 
were interested in the issue of CD were given the possibility of conducting a self-administered 
transglutaminase-based test. The interest of the volunteers in the present study resulted 
mainly from personal motives, such as a relationship with a person suffering from CD, 
deteriorating health and/or distressing nonspecifi c symptoms, or just plain curiosity.
1.1. TTG screening population
The Local Ethical Committee (Olsztyn, Poland) was informed about the screening of the 
population for CD. According to them, the studies did not require acceptation of the 
Committee as a commercial, self-administered immunochromatographic BIOCARD Coeliac 
Test (Labsystems Diagnostics Oy, Vantaa, Finland) was used in the screening. The test 
determines the presence of a coeliac-specifi c IgA anti-tissue transglutaminase antibody 
together with the total serum IgA in a fresh whole blood sample. All CD screening participants 
received a free test to perform individually in accordance with the instructions provided by 
the manufacturer. The possible test results have been presented in Figure 1. All participants 
were under the supervision of a qualifi ed medical paramedic and covered by insurance from 
the effects of dangerous accidents.
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Fig. 1. Possible BIOCARD Coeliac Test results. A: positive test result, a line in the control fi eld (C) and test fi eld 
(T) appears; B: negative test result, a line appears only in the control fi eld (C); C: invalid test or IgA antibody 
defi ciency.
1.2. Knowledge on CD
Among the 300 people who took part in the small-scale tTG population screening, a survey 
concerning their knowledge on CD was carried out. The volunteers signed their informed 
consent to survey data processing prior to the study. Survey participants were asked to fi ll out 
the authors’ original questionnaire containing seven multiple-choice questions. Questions 
concerned mainly the defi nition, aetiology, symptoms, and treatment of CD. Additionally, the 
sociodemographic structure of respondents was recorded.
2. Results and discussion
2.1. Population screening results
Among three hundred BIOCARD coeliac tests performed individually, 5 gave a positive 
result, which represents 1.67% of the population. A Hungarian screening study using rapid 
BIOCARD tests identifi ed 37 newly diagnosed cases of CD among children in a cohort of 
2690 (KORPONAY-SZABÓ et al., 2007). Another study using this test allowed 117 CD persons 
to be identifi ed out of 121 untreated CD patients, which gave results similar to standard 
serological tests (RAIVIO et al., 2006). Nowadays, it is assumed that anywhere from 0.5 to 2% 
of the global population may suffer from CD (REWERS, 2005; GUANDALINI & ASSIRI, 2014), 
including 0.3–1.0% of the European population or those with European ancestry (MEARIN et 
al., 2005). Therefore, it is important to fi nd a quick and cheap way of carrying out mass CD 
screening, especially in groups of increased risk. Although the presence of anti-tTG antibodies 
does not defi nitely mean CD, the results obtained from the present study may suggest a 
higher then suspected prevalence of CD within the analysed population. Each participant 
with a positive test result was encouraged to consult a gastroenterologist and obtained 
information about gastroenterological clinics helpful in further diagnosis.
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2.2. Knowledge on CD
Of the three hundred fi lled out questionnaires obtained, twenty-two (7%) were rejected as the 
responders did not declare their socio-demographic status, or provided incomplete 
information. The remaining 278 questionnaires were analysed. The socio-demographic 
structure of the survey participants is presented in Table 1.
Table 1. Socio-demographic structure of survey participants (N=278)
Survey participants:
Female (N, %) 188, 68
Male (N, %) 90, 32
F/M ratio 1:0.48
Age (years):
18–29 (N, %) 103, 37
30–39 (N, %) 78, 28
40–-49 (N, %) 54, 19
>50 (N, %) 43, 15 
Education:
Primary (N, %) 24, 9 
Secondary (N, %) 75, 27 
Higher (N, %) 179, 64 
Place of residence:
Olsztyn city (N, %) 205, 74
Small city (N, %) 30, 11 
Village (N, %) 43, 15
The fi rst survey question diversifi ed the participants into a dominant group of respondents 
who had heard of the term “coeliac disease” (70%; among them 78% women and 56% men) 
and were asked to answer the remaining questions, and those who had not (30%) and did not 
continue fi lling out the questionnaire. The next question defi ned CD. Nearly all of the 
respondents (94%) correctly defi ned CD as gluten intolerance; among them, 26 individuals 
described CD as both gluten intolerance and the chronic infl ammation of the small intestine 
(Fig. 2A). In the question concerning the age of persons suffering from CD, most respondents 
(nearly 90%) answered that children, adolescents, and adults alike may suffer from the 
disease (Fig. 2B). Until recently, CD was misinterpreted as a “rare disease of young children, 
which they grow out of after a few years of sticking to a proper diet”. This myth of CD being 
a childhood disease continues to be deeply maintained, even in the medical community. The 
last multiple-answer question concerned the symptoms of CD (Fig. 2C). Although all the 
possible answers were correct, only a few of the respondents (29 individuals) indicated all the 
possibilities. In general, gastrointestinal problems were easily associated with CD (87%), 
whereas atypical symptoms, such as constant fatigue, bone and joint pain, and anaemia were 
not always seen as signs of CD. The highly variable clinical picture of CD complicates its 
accurate diagnosis. Patients touched with CD often complain of frank malnutrition, which is 
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a consequence of the malabsorption of several nutrients and vitamins; anaemia and iron 
defi ciency are frequent hematologic manifestations of CD (HARPER et al., 2007). Calcium 
defi ciency in patients suffering from CD affects the reduction of bone mineral density, leading 
to osteopenia and osteoporosis (KRUPA-KOZAK, 2014; GRACE-FARFAGLIA, 2015). Endocrine 
(short stature, delayed puberty) and reproductive disorders (miscarriages, infertility) are also 
observed among people with CD (RIVERA et al., 2013). Therefore, familiarity with the wide 
spectrum of CD symptoms is crucial to its proper diagnosis.
Fig. 2. Answers of respondents participating in the survey for multiple-answer questions: A: “What is coeliac 
disease?”; B: “Who can suffer from coeliac disease”; C: “What are the symptoms of CD?”
The answers of survey participants to the single-answer questions are presented in 
Figure 3. Gluten was correctly identifi ed as the factor responsible for CD development by the 
majority of responders (Fig. 3A). Only 4% of those interviewed pointed to other triggers, 
such as milk proteins and peanuts, which were regarded as incorrect answers. The genetic 
predisposition to CD was the issue tested in the next question. More than half of the 
questionnaire participants realized that the CD may develop in genetically predisposed 
individuals (Fig. 3B). The third question verifi ed the respondents’ knowledge concerning the 
methods of treating CD. The greater part of the interviewed persons correctly selected a GFD 
as the method of treating CD (Fig. 3C). However, 5% of them answered the question 
differently, additionally indicating a diet of easily digestible foods, surgical intervention, or 
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vitamin C as methods of treating the disease. Currently, the only treatment for CD scientifi cally 
proven to be effective is the strict and lifelong exclusion of gluten from one’s diet. It is 
generally accepted that in a GFD, all foods and medications containing gluten from wheat, 
rye, and barley, and their derivatives must be eliminated, as even small quantities of gluten 
may be harmful. The complete removal of gluten from the diet of patients suffering from CD 
results in symptomatic, serologic, and histological remission in a majority of them (FASANO 
& CATASSI, 2001; PIETZAK, 2005). In children with CD, growth and development returns to 
normal with adherence to a GFD, whereas in adults, many disease complications can be 
avoided.
Fig. 3. Answers of respondents participating in the survey to single-answer questions: A: “What it the 
environmental trigger of CD?”: : Gluten; : Other answers.B: „Is CD genetically determined?”: : Yes; : No.
C: “What is the method of treating CD?”: : A gluten-free diet; : Other answers.
3. Conclusions
Based on the results obtained, it can be stated that, in general, self-administered tTG screened 
persons presented a good level of knowledge on CD, regardless of their gender, place of 
residence, or education. The majority of them correctly defi ned CD as gluten intolerance and 
realized that it may occur at any age. Gastrointestinal problems were easily associated with 
CD, however, extra-intestinal symptoms were less frequently recognized as a manifestation 
of the disease. Wherefore, appropriate health education, effective campaigns, and continuous 
popularization of the knowledge concerning the prevalence, symptoms, and treatment of CD 
among the Polish population is very important, as CD, particularly in its atypical and silent 
form, is still an underestimated problem.
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